June 9 () - British drugmaker GSK on Tuesday agreed to acquire U.-listed ‌cancer drug developer Nuvalent for $10.

German industrial production rose more than expected in April and exports unexpectedly rose, bringing some hope for Europe's ...

Citi analysts continue to see upside for oil prices after fading expectations for a near-term U.S.-Iran agreement helped ...

Swiss lawmakers are considering a new pitch to soften capital requirements on UBS that, if implemented, could shave billions ...

Germans are more pessimistic about the economy than Europeans overall, prompting many consumers to save any extra income, ...

The new-look Lotto will give players two chances to win from a single ticket and is expected to double the number of ...

The Italian government will take a neutral stance regarding merger and acquisition moves targeting bank Monte dei Paschi di ...

British home prices will rise less than previously predicted this year and dip in the once flourishing London market as ...

Shares of S4 Capital (LSE:SFOR) traded more than 2% lower on Monday after Morgan Stanley reduced its price target for the ...

Russia is set to reduce its crude oil exports as it plans to boost refinery runs in June amid looming fuel shortages, market ...

Oil prices rose on Monday morning as investors monitored the latest escalation in the Middle East.View on euronews ...

Europe's push to cut its reliance on U. Big Tech with EU-made technologies and chips ‌could shut out other non-EU players ...